AcuCort AB (ACUC.ST)
SEK 0.65
(-3.25%)
SEK 0.65
(-3.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.24 Million SEK | 10.63% |
| 2022 | -14.82 Million SEK | -31.25% |
| 2021 | -11.29 Million SEK | -45.77% |
| 2020 | -7.74 Million SEK | 7.43% |
| 2019 | -8.37 Million SEK | -34.54% |
| 2018 | -6.22 Million SEK | -33.26% |
| 2017 | -4.66 Million SEK | -143.2% |
| 2016 | -1.91 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.56 Million SEK | 9.41% |
| 2024 Q2 | -3.8 Million SEK | -6.77% |
| 2023 Q4 | -3.93 Million SEK | -27.84% |
| 2023 Q3 | -3.07 Million SEK | -8.97% |
| 2023 FY | -13.24 Million SEK | 10.63% |
| 2023 Q2 | -2.82 Million SEK | 17.49% |
| 2023 Q1 | -3.42 Million SEK | 11.44% |
| 2022 Q1 | -3.66 Million SEK | -20.22% |
| 2022 FY | -14.82 Million SEK | -31.25% |
| 2022 Q3 | -3.82 Million SEK | -10.19% |
| 2022 Q2 | -3.47 Million SEK | 5.19% |
| 2022 Q4 | -3.86 Million SEK | -0.91% |
| 2021 Q3 | -2.95 Million SEK | 0.0% |
| 2021 FY | -11.29 Million SEK | -45.77% |
| 2021 Q4 | -3.04 Million SEK | -3.29% |
| 2020 FY | -7.74 Million SEK | 7.43% |
| 2019 FY | -8.37 Million SEK | -34.54% |
| 2018 FY | -6.22 Million SEK | -33.26% |
| 2017 FY | -4.66 Million SEK | -143.2% |
| 2016 FY | -1.91 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AlzeCure Pharma AB (publ) | -38.26 Million SEK | 65.373% |
| BioGaia AB (publ) | 440.9 Million SEK | 103.005% |
| Enzymatica AB (publ) | -48.06 Million SEK | 72.434% |
| Enorama Pharma AB (publ) | -41.83 Million SEK | 68.333% |
| Gabather AB (publ) | -9.47 Million SEK | -39.846% |
| Klaria Pharma Holding AB (publ.) | -14.68 Million SEK | 9.748% |
| Moberg Pharma AB (publ) | -27.46 Million SEK | 51.757% |
| Nanexa AB (publ) | -76.62 Million SEK | 82.709% |
| Newbury Pharmaceuticals AB (publ) | -14.07 Million SEK | 5.889% |
| ODI Pharma AB | -1.34 Million SEK | -887.523% |
| Orexo AB (publ) | -109.5 Million SEK | 87.9% |
| Probi AB (publ) | 11.32 Million SEK | 217.041% |
| Swedencare AB (publ) | 173.2 Million SEK | 107.65% |
| Swedish Orphan Biovitrum AB (publ) | 4.65 Billion SEK | 100.285% |
| Toleranzia AB | -7.89 Million SEK | -67.9% |
| Vivesto AB | -356.71 Million SEK | 96.286% |